Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

After a data breach affected around half of its customers, family ancestry company 23andMe has agreed to a $30 million settlement — and users could be eligible to receive a payout in the future.

EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc ., a global CRO, and Medicover Integrated Clinical ...

Celebration Obstetrics & Gynecology is proud to announce the launch of its new Maternal Fetal Medicine (MFM) division, ...

Some American clinics claim they can ‘rank’ embryos for IVF using a genetic screening system which is illegal in the UK ...

“Winning the Prix Galien Award for Best Medical Technology is an extraordinary testament ... These results suggest that combining RNA and DNA testing could improve genetic detection and help guide ...

BillionToOne, a next-generation molecular diagnostics company, announces three new executive appointments to support its expanding prenatal screening and oncology diagnostics business. Judy Wong joins ...

As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...